Correlation Between Anixa Biosciences and Akero Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Anixa Biosciences and Akero Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Anixa Biosciences and Akero Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Anixa Biosciences and Akero Therapeutics, you can compare the effects of market volatilities on Anixa Biosciences and Akero Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Anixa Biosciences with a short position of Akero Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Anixa Biosciences and Akero Therapeutics.

Diversification Opportunities for Anixa Biosciences and Akero Therapeutics

0.21
  Correlation Coefficient

Modest diversification

The 3 months correlation between Anixa and Akero is 0.21. Overlapping area represents the amount of risk that can be diversified away by holding Anixa Biosciences and Akero Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Akero Therapeutics and Anixa Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Anixa Biosciences are associated (or correlated) with Akero Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Akero Therapeutics has no effect on the direction of Anixa Biosciences i.e., Anixa Biosciences and Akero Therapeutics go up and down completely randomly.

Pair Corralation between Anixa Biosciences and Akero Therapeutics

Given the investment horizon of 90 days Anixa Biosciences is expected to generate 1.57 times less return on investment than Akero Therapeutics. In addition to that, Anixa Biosciences is 1.31 times more volatile than Akero Therapeutics. It trades about 0.01 of its total potential returns per unit of risk. Akero Therapeutics is currently generating about 0.02 per unit of volatility. If you would invest  3,052  in Akero Therapeutics on September 1, 2024 and sell it today you would earn a total of  158.00  from holding Akero Therapeutics or generate 5.18% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Anixa Biosciences  vs.  Akero Therapeutics

 Performance 
       Timeline  
Anixa Biosciences 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Anixa Biosciences are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unsteady forward indicators, Anixa Biosciences may actually be approaching a critical reversion point that can send shares even higher in December 2024.
Akero Therapeutics 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Akero Therapeutics are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of very weak basic indicators, Akero Therapeutics displayed solid returns over the last few months and may actually be approaching a breakup point.

Anixa Biosciences and Akero Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Anixa Biosciences and Akero Therapeutics

The main advantage of trading using opposite Anixa Biosciences and Akero Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Anixa Biosciences position performs unexpectedly, Akero Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Akero Therapeutics will offset losses from the drop in Akero Therapeutics' long position.
The idea behind Anixa Biosciences and Akero Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.

Other Complementary Tools

Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins